Match!
Yizhou Ye
Takeda Pharmaceutical Company
Internal medicineInflammatory bowel diseaseDiabetes mellitusGeneral surgeryMedicine
5Publications
1H-index
1Citations
What is this?
Publications 7
Newest
#1Yizhou YeH-Index: 1
#2Dimitri Bennett (Takeda Pharmaceutical Company)
view all 2 authors...
Source
#1Yizhou Ye (Takeda Pharmaceutical Company)H-Index: 1
#2Sudhakar Manne (Takeda Pharmaceutical Company)H-Index: 4
Last. Dimitri Bennett (Takeda Pharmaceutical Company)
view all 3 authors...
Application of selective algorithms to administrative health claims databases allows detection of specific patients and disease or treatment outcomes. This study identified and applied different al...
Source
#1Yizhou Ye (Takeda Pharmaceutical Company)H-Index: 1
#2Sudhakar Manne (Takeda Pharmaceutical Company)H-Index: 4
Last. Dimitri Bennett (Takeda Pharmaceutical Company)H-Index: 3
view all 4 authors...
3 CitationsSource
#1Yizhou YeH-Index: 1
#2Sudhakar ManneH-Index: 4
Last. Paul DolinH-Index: 5
view all 6 authors...
Source
#1Juha MehtäläH-Index: 8
#2Houssem KhanfirH-Index: 3
Last. Fabian HotiH-Index: 13
view all 6 authors...
Background Studies investigating bladder cancer risk in pioglitazone-treated type 2 diabetes mellitus patients report conflicting results. Previous meta-analyses on this topic utilized publications prior to 2013. More long-term observational studies have been published since then. We reviewed the accumulated evidence and updated findings from previous meta-analyses.
Source
Source
Source
1